8-K: XWELL Reports Q2 2025 Results Amid Strategic Expansion

XWELL, Inc. announced its second quarter 2025 financial results, reporting $7.7 million in revenue and an increased net loss, alongside strategic expansion into new wellness markets.

Summary

• Revenue for the second quarter ended June 30, 2025, totaled approximately $7.7 million.
• This represents a sequential increase from $7.0 million in Q1 2025 but a decrease from $9.3 million in Q2 2024, primarily due to reduced CDC surge billing.
• Cost of sales decreased by approximately 5% and general and administrative expenses decreased by approximately 9% compared to Q2 2024.
• Operating loss for Q2 2025 was approximately $2.7 million, an increase from $1.9 million in Q2 2024.
• Net loss attributable to XWELL for Q2 2025 was approximately $2.3 million, up from $2.0 million in Q2 2024.
• The company had approximately $5.3 million in cash and cash equivalents, $2.9 million in marketable securities, and no long-term debt as of June 30, 2025.
• XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program (TGS) with the CDC and Ginkgo Bioworks Holdings in March 2025.
• Strategic initiatives include being named the official wellness spa of the Orlando Magic, expanding its partnership with Priority Pass, and opening a new non-airport location in Clearwater, Florida.
• Plans are advancing for a new Penn Station location in New York City, and the company is pursuing acquisitions of medical spas in high-demand cities like Orlando, Dallas, and Salt Lake City.

Sentiment

Score: 6

Explanation: While year-over-year financial results show increased losses and decreased revenue, the sequential revenue growth, significant cost reductions, strong liquidity with no long-term debt, and numerous strategic partnerships and expansion initiatives indicate positive momentum and future potential. The negative financial metrics are largely attributed to a specific past event (CDC surge billing), and the company is actively diversifying and growing its core wellness business.

Positives

• Sequential revenue growth from $7.0 million in Q1 2025 to $7.7 million in Q2 2025.
• Cost of sales decreased by approximately 5% and general and administrative expenses decreased by approximately 9% year-over-year, indicating operational discipline.
• Secured a three-year extension of the Traveler-based Genomic Surveillance Program (TGS) with the CDC and Ginkgo Bioworks Holdings, ensuring continued revenue from this segment.
• Named the official wellness spa of the Orlando Magic through a multiyear partnership, marking a significant entry into local markets.
• XpresSpa was recognized as one of Yelp's Most Loved Airport Brands, ranking #10, validating strong customer loyalty.
• Expanded partnership with Priority Pass, enhancing access to wellness services for members.
• Opened a new non-airport brick-and-mortar wellness center in Clearwater, Florida, diversifying operational footprint.
• Advancing plans for a new high-traffic location in New York City's Penn Station.
• Actively pursuing opportunities to acquire medical spas in high-demand cities, indicating strategic growth ambitions.
• Strong liquidity position with approximately $5.3 million in cash and cash equivalents, $2.9 million in marketable securities, and no long-term debt.

Negatives

• Revenue decreased year-over-year from $9.3 million in Q2 2024 to $7.7 million in Q2 2025, primarily due to a reduction in CDC surge billing.
• Operating loss increased to approximately $2.7 million in Q2 2025 from $1.9 million in Q2 2024.
• Net loss attributable to XWELL widened to approximately $2.3 million in Q2 2025 from $2.0 million in Q2 2024.

Risks

• Actual results could differ materially from forward-looking statements due to various risks and uncertainties.
• Important factors that could cause actual results or events to differ are discussed in the company's filings with the SEC, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and proxy statements.

Future Outlook

The company is executing a focused, multi-pronged strategy to expand its operational footprint, increase access to wellness offerings, and deepen customer engagement. This includes advancing plans for a new Penn Station location in New York City and pursuing opportunities to acquire medical spas in high-demand cities like Orlando, Dallas, and Salt Lake City. The long-standing CDC partnership is expected to continue to contribute to the business.

Management Comments

• "The XWELL team delivered a solid second quarter, underscoring the solid momentum we're building across the business."
• "We are currently executing a focused, multi-pronged strategy to expand our operational footprint, increase access to our wellness offerings, and deepen our engagement with both new and existing customers. We believe that these efforts are already delivering measurable results."
• "Coupled with our long-standing CDC partnership, continued operational discipline, and our focused growth strategy, I'm excited by the opportunities that lie ahead."

Industry Context

XWELL operates within the growing consumer wellness market, specifically targeting travel hubs and local communities. Its expansion beyond airports into brick-and-mortar wellness centers and potential medical spa acquisitions aligns with a broader industry trend of making wellness services more accessible and integrated into daily life. The continued biosurveillance program with the CDC positions XWELL at the intersection of public health and travel, a unique niche in the post-pandemic landscape.

Comparison to Industry Standards

• XpresSpa's recognition as one of Yelp's Most Loved Airport Brands (ranking #10) indicates strong customer satisfaction and brand equity within the airport wellness segment, suggesting performance comparable to leading brands in that specific niche.
• The multiyear partnership with the Orlando Magic represents a strategic move into local sports and entertainment markets, a diversification strategy seen in other wellness brands seeking broader consumer engagement beyond their traditional operating environments.
• The expansion of the Priority Pass partnership aligns with the trend of loyalty programs integrating more diverse lifestyle and wellness benefits for their members, similar to how other airport lounge or travel experience providers might expand their offerings.

Stakeholder Impact

• Shareholders: Mixed financial results with increased losses year-over-year, but strategic growth initiatives and cost control could provide long-term value.
• Employees: Continued operations and expansion into new locations suggest stable or growing employment opportunities.
• Customers: Expanded access to wellness services through new locations, partnerships (Priority Pass), and a redesigned website enhances customer experience and reach.
• Suppliers: Continued operations and expansion imply ongoing demand for supplies and services.
• Creditors: No long-term debt and a healthy cash position indicate strong financial stability for creditors.

Next Steps

• Advance plans for the New York City Penn Station location, anticipated to serve as a grab-and-go destination for wellness essentials.
• Pursue opportunities to potentially acquire select medical spas in high-demand cities such as Orlando, Dallas, Texas, and Salt Lake City, Utah.
• Host a webcast and conference call at 5:00 pm Eastern Time on August 14, 2025, to discuss the results.

Key Dates

Recommendation

The company's Q2 2025 results present a mixed picture. While year-over-year revenue declined and losses widened, this was primarily attributed to a specific, non-recurring surge billing from the CDC in the prior year. Positively, the company demonstrated sequential revenue growth, significant cost reductions in both cost of sales and G&A expenses, and maintains a strong liquidity position with no long-term debt. More importantly, XWELL is actively executing a robust strategic expansion plan, including new partnerships (Orlando Magic, Priority Pass), new physical locations, and pursuing M&A in the medical spa sector. These strategic moves, coupled with the extended CDC biosurveillance program, indicate a clear path for future growth and diversification. However, the current profitability challenges warrant a 'hold' stance until these strategic initiatives translate into consistent positive financial performance, particularly in terms of net income.

Keywords

Wellness solutions, Airport services, Biosecurity, XpresSpa, XpresCheck, Naples Wax Center, HyperPointe, Traveler-based Genomic Surveillance Program, CDC partnership, Medical spas, Retail wellness, Nasdaq XWEL